<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02873104</url>
  </required_header>
  <id_info>
    <org_study_id>C-16-TS11</org_study_id>
    <nct_id>NCT02873104</nct_id>
  </id_info>
  <brief_title>Pivotal Study of the truSculpt Radiofrequency Device for Circumferential Reduction</brief_title>
  <official_title>Pivotal Study of the truSculpt Radiofrequency Device for Circumferential Reduction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cutera Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cutera Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the safety and efficacy of the Cutera truSculpt radiofrequency device for
      circumferential reduction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objectives of this study are to evaluate efficacy and safety of treatment with the Cutera
      truSculpt RF device for circumferential reduction in the abdominal and flank region.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Actual">September 2016</completion_date>
  <primary_completion_date type="Actual">September 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Difference in Circumferential Measurement Related to Sham and Therapeutic Group at 12 Weeks Post-treatment</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in Abdominal Circumferential Measurement Related to Sham and Therapeutic Group at 12 Weeks Post-treatment minus Baseline Measurement</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subject Assessment of Improvement for Both Sham Group and Therapeutic Group at 12 Weeks Post-treatment.</measure>
    <time_frame>12 weeks</time_frame>
    <description>Comparison of the average subject improvement score for the sham group and the therapeutic group at 12 weeks post-treatment using a 0 - 4 improvement scale where 0 equals &quot;no change&quot; and 4 equals &quot;Very Significant Improvement&quot;.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject Satisfaction Level for Both Sham Group and Therapeutic Group at 12 Weeks Post-treatment.</measure>
    <time_frame>12 weeks</time_frame>
    <description>Comparison of the average subject satisfaction level for the sham group and therapeutic group at 12 weeks post-treatment, using a 1 - 5 scale where 1 equals &quot;very dissatisfied&quot; and 5 equals &quot;very satisfied&quot;.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject Discomfort and Pain Levels During Treatment</measure>
    <time_frame>12 weeks</time_frame>
    <description>Comparison of the average pain levels during treatment for the sham group and therapeutic group at 12 weeks post-treatment, using a 0 - 10 scale where 0 equals &quot;No pain&quot; and 10 equals &quot;Worst possible pain&quot;.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Abdominal Fat</condition>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>truSculpt rf device, therapeutic settings</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>truSculpt rf device, non-therapeutic settings</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>truSculpt rf device</intervention_name>
    <description>radiofrequency device</description>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_label>Sham</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female or Male, 24 to 60 years of age (inclusive). Fitzpatrick Skin Type I - VI. Has
             visible fat bulges on the abdomen and palpable fat pockets superior to iliac crest
             located bilaterally in the lower back flank region Has a Body Mass Index (BMI) ≥ 20
             and ≤ 30 Non-smoking for at least 6 months and willing to refrain from smoking for the
             duration of the study.

        Subject must agree to not undergo any other procedure(s) in the abdominal and flank region
        during the study period.

        Subject must be able to read, understand and sign the Informed Consent Form. Subject must
        adhere to the follow-up schedule and study instructions. Subject must adhere to the same
        diet and/or exercise routine throughout the study, and agree to maintain the same weight
        throughout the study, within 5% of baseline weight measurement.

        Willing to have digital photographs taken of the treatment area and agree to use of
        photographs for presentation, educational or marketing purposes.

        Post-menopausal or surgically sterilized, or using a medically acceptable form of birth
        control at least 3 months prior to enrollment and during the entire course of the study,
        and no plans to become pregnant.

        Exclusion Criteria:

          -  Participation in a clinical trial of another device or drug within 6 months of study
             participation, or during the study period.

        Any type of prior cosmetic treatment to the target area within 12 months of study
        participation e.g., radiofrequency, cryolysis or light-based treatments.

        Any prior invasive cosmetic surgery to the target area, such as liposuction. Currently
        taking medications or supplements for weight-loss or metabolism support/enhancement or has
        a history of taking such medications or supplements within 3 months.

        Has a pacemaker, internal defibrillator, implantable cardioverter-defibrillator, nerve
        stimulator implant, cochlear implant or any other electronically, magnetically or
        mechanically activated implant.

        Has metal implant(s) within the body, such as surgical clips, plates and screws,
        intrauterine device (IUD), artificial heart valves or artificial joints.

        Significant concurrent illness, such as diabetes mellitus, cardiovascular disease,
        peripheral vascular disease or pertinent neurological disorders.

        Diagnosed or documented immune system disorders. History of any disease or condition that
        could impair wound healing. History of diseases stimulated by heat, such as recurrent
        herpes zoster in the treatment area, unless treatment is conducted following a prophylactic
        regimen.

        History of keloid formation, hypertrophic scarring or abnormal/delayed wound healing.

        Infection, dermatitis, rash or other skin abnormality in the target area. Currently
        undergoing systemic chemotherapy or radiation treatment for cancer, or history of treatment
        in the target area within 3 months of study participation.

        Pregnant or currently breastfeeding. As per the Investigator's discretion, any physical or
        mental condition which might make it unsafe for the subject to participate in this study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>24 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Cutera Research Center</name>
      <address>
        <city>Brisbane</city>
        <state>California</state>
        <zip>94005</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 16, 2016</study_first_submitted>
  <study_first_submitted_qc>August 16, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 19, 2016</study_first_posted>
  <results_first_submitted>December 13, 2016</results_first_submitted>
  <results_first_submitted_qc>January 31, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">February 28, 2018</results_first_posted>
  <last_update_submitted>January 31, 2018</last_update_submitted>
  <last_update_submitted_qc>January 31, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Treatment</title>
          <description>truSculpt rf device, therapeutic settings
truSculpt rf device: radiofrequency device</description>
        </group>
        <group group_id="P2">
          <title>Sham</title>
          <description>truSculpt rf device, non-therapeutic settings
truSculpt rf device: radiofrequency device</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="47"/>
                <participants group_id="P2" count="23"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="46"/>
                <participants group_id="P2" count="23"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Treatment</title>
          <description>truSculpt rf device, therapeutic settings
truSculpt rf device: radiofrequency device</description>
        </group>
        <group group_id="B2">
          <title>Sham</title>
          <description>truSculpt rf device, non-therapeutic settings
truSculpt rf device: radiofrequency device</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="47"/>
            <count group_id="B2" value="23"/>
            <count group_id="B3" value="70"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="47"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="70"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="37"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="45"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Difference in Circumferential Measurement Related to Sham and Therapeutic Group at 12 Weeks Post-treatment</title>
        <description>Change in Abdominal Circumferential Measurement Related to Sham and Therapeutic Group at 12 Weeks Post-treatment minus Baseline Measurement</description>
        <time_frame>12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Treatment</title>
            <description>truSculpt rf device, therapeutic settings
truSculpt rf device: radiofrequency device</description>
          </group>
          <group group_id="O2">
            <title>Sham</title>
            <description>truSculpt rf device, non-therapeutic settings
truSculpt rf device: radiofrequency device</description>
          </group>
        </group_list>
        <measure>
          <title>Difference in Circumferential Measurement Related to Sham and Therapeutic Group at 12 Weeks Post-treatment</title>
          <description>Change in Abdominal Circumferential Measurement Related to Sham and Therapeutic Group at 12 Weeks Post-treatment minus Baseline Measurement</description>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.9" spread="0.1"/>
                    <measurement group_id="O2" value="0" spread="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subject Assessment of Improvement for Both Sham Group and Therapeutic Group at 12 Weeks Post-treatment.</title>
        <description>Comparison of the average subject improvement score for the sham group and the therapeutic group at 12 weeks post-treatment using a 0 - 4 improvement scale where 0 equals &quot;no change&quot; and 4 equals &quot;Very Significant Improvement&quot;.</description>
        <time_frame>12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Treatment</title>
            <description>truSculpt rf device, therapeutic settings
truSculpt rf device: radiofrequency device</description>
          </group>
          <group group_id="O2">
            <title>Sham</title>
            <description>truSculpt rf device, non-therapeutic settings
truSculpt rf device: radiofrequency device</description>
          </group>
        </group_list>
        <measure>
          <title>Subject Assessment of Improvement for Both Sham Group and Therapeutic Group at 12 Weeks Post-treatment.</title>
          <description>Comparison of the average subject improvement score for the sham group and the therapeutic group at 12 weeks post-treatment using a 0 - 4 improvement scale where 0 equals &quot;no change&quot; and 4 equals &quot;Very Significant Improvement&quot;.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.4" spread="1"/>
                    <measurement group_id="O2" value="1" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subject Satisfaction Level for Both Sham Group and Therapeutic Group at 12 Weeks Post-treatment.</title>
        <description>Comparison of the average subject satisfaction level for the sham group and therapeutic group at 12 weeks post-treatment, using a 1 - 5 scale where 1 equals &quot;very dissatisfied&quot; and 5 equals &quot;very satisfied&quot;.</description>
        <time_frame>12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Treatment</title>
            <description>truSculpt rf device, therapeutic settings
truSculpt rf device: radiofrequency device</description>
          </group>
          <group group_id="O2">
            <title>Sham</title>
            <description>truSculpt rf device, non-therapeutic settings
truSculpt rf device: radiofrequency device</description>
          </group>
        </group_list>
        <measure>
          <title>Subject Satisfaction Level for Both Sham Group and Therapeutic Group at 12 Weeks Post-treatment.</title>
          <description>Comparison of the average subject satisfaction level for the sham group and therapeutic group at 12 weeks post-treatment, using a 1 - 5 scale where 1 equals &quot;very dissatisfied&quot; and 5 equals &quot;very satisfied&quot;.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.1" spread="0.8"/>
                    <measurement group_id="O2" value="3.3" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subject Discomfort and Pain Levels During Treatment</title>
        <description>Comparison of the average pain levels during treatment for the sham group and therapeutic group at 12 weeks post-treatment, using a 0 - 10 scale where 0 equals &quot;No pain&quot; and 10 equals &quot;Worst possible pain&quot;.</description>
        <time_frame>12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Treatment</title>
            <description>truSculpt rf device, therapeutic settings
truSculpt rf device: radiofrequency device</description>
          </group>
          <group group_id="O2">
            <title>Sham</title>
            <description>truSculpt rf device, non-therapeutic settings
truSculpt rf device: radiofrequency device</description>
          </group>
        </group_list>
        <measure>
          <title>Subject Discomfort and Pain Levels During Treatment</title>
          <description>Comparison of the average pain levels during treatment for the sham group and therapeutic group at 12 weeks post-treatment, using a 0 - 10 scale where 0 equals &quot;No pain&quot; and 10 equals &quot;Worst possible pain&quot;.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="47"/>
                <count group_id="O2" value="23"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.75" spread="0.9"/>
                    <measurement group_id="O2" value="1.1" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Treatment</title>
          <description>truSculpt rf device, therapeutic settings
truSculpt rf device: radiofrequency device</description>
        </group>
        <group group_id="E2">
          <title>Sham</title>
          <description>truSculpt rf device, non-therapeutic settings
truSculpt rf device: radiofrequency device</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="47" subjects_at_risk="47"/>
                <counts group_id="E2" subjects_affected="23" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Erythema</sub_title>
                <counts group_id="E1" events="47" subjects_affected="47" subjects_at_risk="47"/>
                <counts group_id="E2" events="23" subjects_affected="23" subjects_at_risk="23"/>
              </event>
              <event>
                <sub_title>Edema</sub_title>
                <counts group_id="E1" events="47" subjects_affected="47" subjects_at_risk="47"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Lourdes Moldre, NP</name_or_title>
      <organization>Cutera</organization>
      <phone>415-971-5118</phone>
      <email>lmoldre@cutera.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

